Diopter Technologies

Diopter Corporation has developed a proprietary medical device that combines an amniotic membrane with a biopolymer to create a single-use, bioresorbable contact lens for treating corneal wounds. This innovative technology offers a non-surgical alternative to traditional amniotic membrane surgical grafts, which have been proven effective in reducing corneal scarring, blood vessel growth, and blindness. The Diopter lens provides a new, non-surgical method for deploying the benefits of amniotic membrane surgical graft technology. The company consists of seasoned management that invented, developed and commercialized a first-generation amniotic coated contact lens to treat corneal scars. The first-generation product is the leading product in the corneal wound healing business and has been used on over 1,000,000 patients. That technology was purchased by a leading ophthalmic surgical products company.

• Employees 2